Artwork

Content provided by Venrock and A venture capital firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Venrock and A venture capital firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Balancing Act of Drug Discovery

29:48
 
Share
 

Manage episode 341823794 series 1016848
Content provided by Venrock and A venture capital firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Venrock and A venture capital firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Larry Hamann, co-founder, president, and CEO of Interdict Bio, speaks with Venrock Vice President Mariana Mihalusova about lessons learned from his career in drug discovery. Hamann delves into where his love for organic chemistry stems from and why inclusive environments are essential to building successful teams. He also speaks about the do’s and don'ts when structuring collaborations with big pharma, when a drug is “good enough” to move forward in development and new approaches he's excited for.

  continue reading

102 episodes

Artwork
iconShare
 
Manage episode 341823794 series 1016848
Content provided by Venrock and A venture capital firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Venrock and A venture capital firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Larry Hamann, co-founder, president, and CEO of Interdict Bio, speaks with Venrock Vice President Mariana Mihalusova about lessons learned from his career in drug discovery. Hamann delves into where his love for organic chemistry stems from and why inclusive environments are essential to building successful teams. He also speaks about the do’s and don'ts when structuring collaborations with big pharma, when a drug is “good enough” to move forward in development and new approaches he's excited for.

  continue reading

102 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide